Literature DB >> 8689646

Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin.

H H Sigusch1, S E Campbell, K T Weber.   

Abstract

OBJECTIVE: Chronic elevations in plasma angiotensin II (AngII) are associated with an efflux of plasma macromolecules into the perivascular and contiguous interstitial space. This is followed by the appearance of macrophages and type I collagen-producing, fibroblast-like cells that precede the accumulation of fibrous tissue at these sites. Whether this perivascular and interstitial fibrosis is a direct effect of AngII on collagen turnover of these cells or an indirect response mediated by nitric oxide, prostaglandins and/or bradykinin released in response to AngII, is uncertain.
METHODS: We measured perivascular and interstitial fibrosis (picrosirius-stained tissue) in response to 14-day infusion of AngII (150 ng/kg/min, s.c.) in male Sprague-Dawley rats. Treated animals were compared to untreated controls and to groups receiving AngII together with either an NO-synthase inhibitor [NG-nitro-L-arginine methyl ester (L-NAME) 10 mg/kg/day in drinking water], a cyclo-oxygenase inhibitor (indomethacin, 2 mg/kg/day in drinking water), or a bradykinin B2 receptor antagonist (Hoe140, 115 ng/kg/min, s.c.).
RESULTS: When left and right ventricles of treated rats were compared to untreated controls, AngII led to a respective 68 and 48% increase in perivascular collagen volume fraction (PCVF) and a 54 and 22% increase in interstitial collagen volume fraction (ICVF). Co-administration of AngII + L-NAME did not attenuate either PCVF or ICVF while indomethacin significantly attenuated PCVF by 37 and 33% of left and right ventricle, respectively, but did not alter ICVF in either ventricle when compared to AngII-treated animals. Co-administration of AngII + Hoe140 completely prevented perivascular and interstitial collagen accumulation with the extent of perivascular fibrosis comparable to untreated controls.
CONCLUSION: The perivascular and interstitial fibrosis of the rat right and left ventricles seen in association with the exogenous administration of AngII is mediated by the release of bradykinin and prostaglandins, and therefore is an indirect response to elevated circulating AngII.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8689646

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

Review 1.  Adverse Remodeling and Reverse Remodeling After Myocardial Infarction.

Authors:  Ankeet S Bhatt; Andrew P Ambrosy; Eric J Velazquez
Journal:  Curr Cardiol Rep       Date:  2017-08       Impact factor: 2.931

2.  Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.

Authors:  M Takemoto; K Egashira; M Usui; K Numaguchi; H Tomita; H Tsutsui; H Shimokawa; K Sueishi; A Takeshita
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

Review 3.  The extracellular matrix and the cytoskeleton in heart hypertrophy and failure.

Authors:  S Jane-Lise; S Corda; C Chassagne; L Rappaport
Journal:  Heart Fail Rev       Date:  2000-10       Impact factor: 4.214

Review 4.  Extracellular matrix and growth factors during heart growth.

Authors:  S Corda; J L Samuel; L Rappaport
Journal:  Heart Fail Rev       Date:  2000-06       Impact factor: 4.214

5.  Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts.

Authors:  LaTronya T McCollum; Patricia E Gallagher; E Ann Tallant
Journal:  Peptides       Date:  2012-02-02       Impact factor: 3.750

Review 6.  Disruptions and detours in the myocardial matrix highway and heart failure.

Authors:  Anne M Deschamps; Francis G Spinale
Journal:  Curr Heart Fail Rep       Date:  2005-03

7.  Effects of a novel ACE inhibitor, 3-(3-thienyl)-l-alanyl-ornithyl-proline, on endothelial vasodilation and hepatotoxicity in l-NAME-induced hypertensive rats.

Authors:  Mahesh Kumar Seth; M Ejaz Hussain; Santosh Pasha; Mohammad Fahim
Journal:  Drug Des Devel Ther       Date:  2016-04-20       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.